Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to reduce serum phosphorus in adults with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among patients with kidney and/or heart failure; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. more
Time Frame | ARDX | Sector | S&P500 |
---|---|---|---|
1-Week Return | 2.56% | 2.44% | 2.58% |
1-Month Return | -10.09% | -4.49% | 0.09% |
3-Month Return | -24.37% | -8.82% | 4.76% |
6-Month Return | -21.28% | -4.46% | 9.89% |
1-Year Return | -25.66% | 3.16% | 26.47% |
3-Year Return | 345.37% | -0.83% | 25.98% |
5-Year Return | -36.54% | 35.65% | 86.34% |
10-Year Return | -77.57% | 101.94% | 189.21% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 5.28M | 7.57M | 10.10M | 52.16M | 124.46M | [{"date":"2019-12-31","value":4.24,"profit":true},{"date":"2020-12-31","value":6.08,"profit":true},{"date":"2021-12-31","value":8.11,"profit":true},{"date":"2022-12-31","value":41.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 600.00K | 145.00K | 1.00M | 4.12M | 17.80M | [{"date":"2019-12-31","value":3.37,"profit":true},{"date":"2020-12-31","value":0.81,"profit":true},{"date":"2021-12-31","value":5.62,"profit":true},{"date":"2022-12-31","value":23.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 4.68M | 7.43M | 9.10M | 48.04M | 106.66M | [{"date":"2019-12-31","value":4.39,"profit":true},{"date":"2020-12-31","value":6.96,"profit":true},{"date":"2021-12-31","value":8.53,"profit":true},{"date":"2022-12-31","value":45.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 88.64% | 98.08% | 90.10% | 92.11% | 85.70% | [{"date":"2019-12-31","value":90.37,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":91.86,"profit":true},{"date":"2022-12-31","value":93.91,"profit":true},{"date":"2023-12-31","value":87.38,"profit":true}] |
Operating Expenses | 95.94M | 98.21M | 163.44M | 111.80M | 169.94M | [{"date":"2019-12-31","value":56.46,"profit":true},{"date":"2020-12-31","value":57.79,"profit":true},{"date":"2021-12-31","value":96.18,"profit":true},{"date":"2022-12-31","value":65.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (91.26M) | (90.78M) | (154.35M) | (63.76M) | (63.28M) | [{"date":"2019-12-31","value":-9126300000,"profit":false},{"date":"2020-12-31","value":-9078000000,"profit":false},{"date":"2021-12-31","value":-15434600000,"profit":false},{"date":"2022-12-31","value":-6375900000,"profit":false},{"date":"2023-12-31","value":-6327600000,"profit":false}] |
Total Non-Operating Income/Expense | (9.10M) | (8.63M) | (8.32M) | (8.51M) | (11.12M) | [{"date":"2019-12-31","value":-910000000,"profit":false},{"date":"2020-12-31","value":-863000000,"profit":false},{"date":"2021-12-31","value":-831700000,"profit":false},{"date":"2022-12-31","value":-851300000,"profit":false},{"date":"2023-12-31","value":-1111800000,"profit":false}] |
Pre-Tax Income | (94.64M) | (94.31M) | (158.16M) | (67.20M) | (65.52M) | [{"date":"2019-12-31","value":-9463700000,"profit":false},{"date":"2020-12-31","value":-9431100000,"profit":false},{"date":"2021-12-31","value":-15816100000,"profit":false},{"date":"2022-12-31","value":-6719900000,"profit":false},{"date":"2023-12-31","value":-6552000000,"profit":false}] |
Income Taxes | 303.00K | 2.00K | 4.00K | 8.00K | 547.00K | [{"date":"2019-12-31","value":55.39,"profit":true},{"date":"2020-12-31","value":0.37,"profit":true},{"date":"2021-12-31","value":0.73,"profit":true},{"date":"2022-12-31","value":1.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (94.94M) | (94.31M) | (158.16M) | (67.21M) | (66.07M) | [{"date":"2019-12-31","value":-9494000000,"profit":false},{"date":"2020-12-31","value":-9431300000,"profit":false},{"date":"2021-12-31","value":-15816500000,"profit":false},{"date":"2022-12-31","value":-6720700000,"profit":false},{"date":"2023-12-31","value":-6606700000,"profit":false}] |
Income From Continuous Operations | (94.94M) | (94.31M) | (158.16M) | (67.21M) | (66.07M) | [{"date":"2019-12-31","value":-9494000000,"profit":false},{"date":"2020-12-31","value":-9431300000,"profit":false},{"date":"2021-12-31","value":-15816500000,"profit":false},{"date":"2022-12-31","value":-6720700000,"profit":false},{"date":"2023-12-31","value":-6606700000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (94.94M) | (94.31M) | (158.16M) | (67.21M) | (66.07M) | [{"date":"2019-12-31","value":-9494000000,"profit":false},{"date":"2020-12-31","value":-9431300000,"profit":false},{"date":"2021-12-31","value":-15816500000,"profit":false},{"date":"2022-12-31","value":-6720700000,"profit":false},{"date":"2023-12-31","value":-6606700000,"profit":false}] |
EPS (Diluted) | (1.47) | (1.05) | (1.52) | (0.48) | (0.30) | [{"date":"2019-12-31","value":-147,"profit":false},{"date":"2020-12-31","value":-105,"profit":false},{"date":"2021-12-31","value":-152,"profit":false},{"date":"2022-12-31","value":-48,"profit":false},{"date":"2023-12-31","value":-30,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
ARDX | |
---|---|
Cash Ratio | 2.70 |
Current Ratio | 4.03 |
Quick Ratio | 3.87 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ARDX | |
---|---|
ROA (LTM) | -12.18% |
ROE (LTM) | -41.54% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ARDX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.57 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.43 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ARDX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 4.31 |
P/B | 6.85 |
Price/FCF | 2980 |
EV/R | 3.97 |
EV/Ebitda | NM |
PEG | NM |
Ardelyx Inc (ARDX) share price today is $4.81
Yes, Indians can buy shares of Ardelyx Inc (ARDX) on Vested. To buy Ardelyx Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ARDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Ardelyx Inc (ARDX) via the Vested app. You can start investing in Ardelyx Inc (ARDX) with a minimum investment of $1.
You can invest in shares of Ardelyx Inc (ARDX) via Vested in three simple steps:
The 52-week high price of Ardelyx Inc (ARDX) is $10.13. The 52-week low price of Ardelyx Inc (ARDX) is $4.32.
The price-to-earnings (P/E) ratio of Ardelyx Inc (ARDX) is
The price-to-book (P/B) ratio of Ardelyx Inc (ARDX) is 6.85
The dividend yield of Ardelyx Inc (ARDX) is 0.00%
The market capitalization of Ardelyx Inc (ARDX) is $1.08B
The stock symbol (or ticker) of Ardelyx Inc is ARDX